eli lilly glp 1 pipeline does become a trillion dollar pharma company with this glp-1 pipeline? i think so Eli Lilly Strengthens Its Weight

The compound never made it through formal drug development

This biological difference means that the mechanism driving C-cell tumors in rats, chronic GLP-1 receptor stimulation leading to C-cell proliferation, may simply not operate in human thyroid tissue, or at least not at anywhere near the same intensity

Huang Z, Wong L-W, Su Y, Huang X, Wang N, Chen H, et al

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

10.1111/jpi.12491 30 DongL.SunQ.QiuH.YangK.XiaoB.XiaT.et al (2023a)

Most patients begin here and stay here, as the 5mg dose is sufficient for meaningful cognitive benefits in the majority of cases